Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction
Bausch + Lomb $1.75 billion financing for acquisition of certain Novartis assets
We are advising Bausch + Lomb on the financing
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera
LifeScan Global refinancing and amendment to credit facilities
We advised an ad hoc group of term lenders in connection with the transaction
Merck $6 billion revolving credit facility
We advised the agent, arrangers and lenders on the financing
Prospect Medical Holdings $375 million refinancing
We advised the administrative agent and collateral agent in connection with the existing ABL credit facility
Envision Healthcare and AmSurg chapter 11 restructuring
We are advising the administrative and collateral agent in connection with AmSurg’s restructuring
Envision Healthcare chapter 11 restructuring
We are advising the administrative agent and collateral agent in connection with Envision Healthcare's restructuring
Invacare chapter 11 plan confirmed
We advised the prepetition term loan agent and escrow agent on the transaction